AtriCure, Inc.
ATRC
$28.89
$0.100.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.53% | 4.64% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.53% | 4.64% | |||
| Cost of Revenue | -9.17% | 6.76% | |||
| Gross Profit | 3.77% | 3.95% | |||
| SG&A Expenses | 7.93% | 0.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.97% | 2.94% | |||
| Operating Income | -78.88% | 1,097.60% | |||
| Income Before Tax | -83.31% | 2,844.19% | |||
| Income Tax Expenses | -52.65% | 233.70% | |||
| Earnings from Continuing Operations | -93.85% | 757.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -93.85% | 757.68% | |||
| EBIT | -78.88% | 1,097.60% | |||
| EBITDA | -23.68% | 41.31% | |||
| EPS Basic | -93.99% | 753.57% | |||
| Normalized Basic EPS | -83.44% | 2,900.00% | |||
| EPS Diluted | -93.87% | 741.07% | |||
| Normalized Diluted EPS | -83.44% | 2,845.45% | |||
| Average Basic Shares Outstanding | 0.78% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.35% | 1.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||